whatshot

CSII   $20.0  0.10% Market Closed

Cardiovascular Systems Inc
show_chart Advanced Chart of CSII
Last Events:

2023-04-28 Signal in Stochastic changed from bullish recovery to bearish reversal. The stochastic indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: main and signal line crossing.

2023-03-30 Trend pattern changed from канал to восходящий треугольник.

2023-03-30 Signal in Stochastic changed from bullish to bullish recovery. The stochastic indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: main and signal line crossing.

2023-03-30 Signal in MACD changed from bullish to bearish reversal. Oscillator MACD is in the positive territory it's lower than the signal line and falls. These factors mean that the growing period is over. Last signal: exit from the overbought zone.

2023-03-30 Signal in RSI changed from bullish weakening to bullish recovery. RSI indicator is in overbought territory and it heading south. These factors indicate that perhaps the upside trend is coming to an end. Last signal: entrance to the overbought zone.

2023-03-30 Trend Power changed from to strong.

2023-03-30 Trend changed from down and flat to turning up.

2023-03-29 Trend pattern changed from восходящий треугольник to канал.

Current temperature: 0.33
ST: 0, Cor:

50-50 Year Forecast
Low with 50% probability: 15.77
Target: 17.40
High with 50% probability: 23.43
Analyst Recommendations:
Number of estimates 5
Target Price Mean 17.40
Mean unverified/preliminary 17.40 / 17.40
Target Price Low / High 14.00 / 20.00
Median / STD DEV 18.00 / 2.79
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell -
rsi Sell Sell -
macd - - -
stoch - - -
ma20 Sell - -
ma50 - - -
ma100 Sell Sell -
Candlestick PatternApril 20, 2023 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US1416191062
ceo Mr. Scott Raymond Ward B.Sc., M.S., MS
Website https://www.csi360.com
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. In addition, it offers guidewires, catheters, balloons, embolic protection system, and other OAS support products. Cardiovascular Systems, Inc. has a partnership with Chansu Vascular Technologies, LLC to develop novel peripheral and coronary everolimus drug-coated balloons. The company was formerly known as Shturman Cardiology Systems, Inc. and changed its name to Cardiovascular Systems, Inc. in January 2003. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota. As of April 27, 2023, Cardiovascular Systems, Inc. operates as subsidiary of Abbott Laboratories (NYSE:ABT).